These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26761780)

  • 1. Cell source determines the immunological impact of biomimetic nanoparticles.
    Evangelopoulos M; Parodi A; Martinez JO; Yazdi IK; Cevenini A; van de Ven AL; Quattrocchi N; Boada C; Taghipour N; Corbo C; Brown BS; Scaria S; Liu X; Ferrari M; Tasciotti E
    Biomaterials; 2016 Mar; 82():168-77. PubMed ID: 26761780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomimetic carriers mimicking leukocyte plasma membrane to increase tumor vasculature permeability.
    Palomba R; Parodi A; Evangelopoulos M; Acciardo S; Corbo C; de Rosa E; Yazdi IK; Scaria S; Molinaro R; Furman NE; You J; Ferrari M; Salvatore F; Tasciotti E
    Sci Rep; 2016 Oct; 6():34422. PubMed ID: 27703233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic Profiling of a Biomimetic Drug Delivery Platform.
    Corbo C; Parodi A; Evangelopoulos M; Engler DA; Matsunami RK; Engler AC; Molinaro R; Scaria S; Salvatore F; Tasciotti E
    Curr Drug Targets; 2015; 16(13):1540-7. PubMed ID: 25382209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions.
    Parodi A; Quattrocchi N; van de Ven AL; Chiappini C; Evangelopoulos M; Martinez JO; Brown BS; Khaled SZ; Yazdi IK; Enzo MV; Isenhart L; Ferrari M; Tasciotti E
    Nat Nanotechnol; 2013 Jan; 8(1):61-8. PubMed ID: 23241654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioengineering CXCR4-overexpressing cell membrane functionalized ROS-responsive nanotherapeutics for targeting cerebral ischemia-reperfusion injury.
    Luo L; Zang G; Liu B; Qin X; Zhang Y; Chen Y; Zhang H; Wu W; Wang G
    Theranostics; 2021; 11(16):8043-8056. PubMed ID: 34335979
    [No Abstract]   [Full Text] [Related]  

  • 6. Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications.
    Wang Y; Zhang K; Li T; Maruf A; Qin X; Luo L; Zhong Y; Qiu J; McGinty S; Pontrelli G; Liao X; Wu W; Wang G
    Theranostics; 2021; 11(1):164-180. PubMed ID: 33391468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomimetic nanoarchitecturing: A disguised attack on cancer cells.
    Jha A; Nikam AN; Kulkarni S; Mutalik SP; Pandey A; Hegde M; Rao BSS; Mutalik S
    J Control Release; 2021 Jan; 329():413-433. PubMed ID: 33301837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface Functionalization of Polymeric Nanoparticles with Umbilical Cord-Derived Mesenchymal Stem Cell Membrane for Tumor-Targeted Therapy.
    Yang N; Ding Y; Zhang Y; Wang B; Zhao X; Cheng K; Huang Y; Taleb M; Zhao J; Dong WF; Zhang L; Nie G
    ACS Appl Mater Interfaces; 2018 Jul; 10(27):22963-22973. PubMed ID: 29905067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocyte-Mediated Combined Targeted Chemo and Gene Therapy for Esophageal Cancer.
    Jun Y; Tang Z; Luo C; Jiang B; Li X; Tao M; Gu H; Liu L; Zhang Z; Sun S; Han K; Yu X; Song X; Tao G; Chen X; Zhang L; Gao Y; Wang QL
    ACS Appl Mater Interfaces; 2020 Oct; 12(42):47330-47341. PubMed ID: 32997489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Biomimetic Gold Nanocages-Based Nanoplatform for Efficient Tumor Ablation and Reduced Inflammation.
    Xu Q; Wan J; Bie N; Song X; Yang X; Yong T; Zhao Y; Yang X; Gan L
    Theranostics; 2018; 8(19):5362-5378. PubMed ID: 30555552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomimetic nanoparticles with enhanced affinity towards activated endothelium as versatile tools for theranostic drug delivery.
    Martinez JO; Molinaro R; Hartman KA; Boada C; Sukhovershin R; De Rosa E; Kirui D; Zhang S; Evangelopoulos M; Carter AM; Bibb JA; Cooke JP; Tasciotti E
    Theranostics; 2018; 8(4):1131-1145. PubMed ID: 29464004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Size Dependency of Circulation and Biodistribution of Biomimetic Nanoparticles: Red Blood Cell Membrane-Coated Nanoparticles.
    Li H; Jin K; Luo M; Wang X; Zhu X; Liu X; Jiang T; Zhang Q; Wang S; Pang Z
    Cells; 2019 Aug; 8(8):. PubMed ID: 31412631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomimetic and bioinspired nanoparticles for targeted drug delivery.
    Gagliardi M
    Ther Deliv; 2017 Mar; 8(5):289-299. PubMed ID: 28361608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing Inflammation Targeting Using Tunable Leukocyte-Based Biomimetic Nanoparticles.
    Zinger A; Sushnitha M; Naoi T; Baudo G; De Rosa E; Chang J; Tasciotti E; Taraballi F
    ACS Nano; 2021 Apr; 15(4):6326-6339. PubMed ID: 33724785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coating nanoparticles with cell membranes for targeted drug delivery.
    Gao W; Zhang L
    J Drug Target; 2015; 23(7-8):619-26. PubMed ID: 26453159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved In Vitro and In Vivo Biocompatibility of Graphene Oxide through Surface Modification: Poly(Acrylic Acid)-Functionalization is Superior to PEGylation.
    Xu M; Zhu J; Wang F; Xiong Y; Wu Y; Wang Q; Weng J; Zhang Z; Chen W; Liu S
    ACS Nano; 2016 Mar; 10(3):3267-81. PubMed ID: 26855010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfluorodecalin-Filled Poly(n-butyl-cyanoacrylate) Nanocapsules as Potential Artificial Oxygen Carriers: Preclinical Safety and Biocompatibility.
    Laudien J; Groß-Heitfeld C; Mayer C; de Groot H; Kirsch M; Ferenz KB
    J Nanosci Nanotechnol; 2015 Aug; 15(8):5637-48. PubMed ID: 26369130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulatory Role of Surface Coating of Superparamagnetic Iron Oxide Nanoworms in Complement Opsonization and Leukocyte Uptake.
    Inturi S; Wang G; Chen F; Banda NK; Holers VM; Wu L; Moghimi SM; Simberg D
    ACS Nano; 2015 Nov; 9(11):10758-68. PubMed ID: 26488074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanovector Assembled from Natural Egg Yolk Lipids for Tumor-Targeted Delivery of Therapeutics.
    Tang Z; Luo C; Jun Y; Yao M; Zhang M; He K; Jin L; Ma J; Chen S; Sun S; Tao M; Ding L; Sun X; Chen X; Zhang L; Gao Y; Wang QL
    ACS Appl Mater Interfaces; 2020 Feb; 12(7):7984-7994. PubMed ID: 31971362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of polymer and linker chemistries on the efficacy of immunocamouflage of murine leukocytes.
    Chen AM; Scott MD
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(3):305-22. PubMed ID: 16809132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.